Vanguard Group Inc Genocea Biosciences, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.01 - $1.38 $15,749 - $2.17 Million	-1,574,979 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.96 - $1.35 $96 - $135	100 Added 0.01%	1,574,979 $1.97 Million
Q4 2021 Feb 14, 2022	BUY	$0.95 - $1.99 $11,189 - $23,438	11,778 Added 0.75%	1,574,879 $1.83 Million
Q3 2021 Nov 12, 2021	BUY	$1.74 - $2.33 $42,870 - $57,406	24,638 Added 1.6%	1,563,101 $3 Million
Q2 2021 Aug 13, 2021	BUY	$2.06 - $2.82 $3.17 Million - $4.34 Million	1,538,463 New	1,538,463 $3.6 Million

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.